US private equity group Horizon Capital has made an undisclosed investment in marketing technology company Viseven, which serves the pharma and life sciences sectors.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.